London, Dec. 7, 2024 /Mpelembe Network/ — Network is celebrating Gemini’s first anniversary. This is a fantastic opportunity to reflect on its achievements and look forward to the future. Here are a few ideas on how we aim to commemorate this special occasion: Continue reading
Tag Archives: Multimodal interaction
Vuzix Smart Glasses Support New Partnership Designed to Solve Global Health Workforce Shortages
Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that its smart glasses have been selected to support a new partnership between med-tech specialist Global Health Education Group (“GHEG”) and the University of Leeds, one of the largest higher education institutions in the UK. GHEG has developed an online learning tool designed to significantly increase the accessibility, scale and quality of clinical training opportunities available to healthcare students. Continue reading
Vuzix Announces General Availability of M400C Smart Glasses
Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that its Vuzix M400C™ smart glasses are now available for customer orders in the US, Canada, UK, EU and Japan. Vuzix M400C smart glasses list for $1299.99 and interested customers should contact the Company sales department directly. Continue reading
Vuzix M400 Smart Glasses Begin Use Case in Japan for Ambulance Emergency Medical Care
Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that its M400 smart glasses are currently being trialed in Japan for an emergency medical care plan with the objective of providing early treatment in an effort to improve patient outcomes and lifesaving rates for critically ill patients undergoing transport to the hospital. The collaborative effort on this trial involves Juntendo University, Shizuoka Hospital, the Shunto Izu Fire Department, and AVR Japan Co., Ltd. Continue reading